The epithelial Mg2+ channel transient receptor potential melastatin 6 is regulated by dietary Mg2+ content and estrogens. by Tiel Groenestege, W.M. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/49773
 
 
 
Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
The Epithelial Mg2 Channel Transient Receptor Potential
Melastatin 6 Is Regulated by Dietary Mg2 Content
and Estrogens
Wouter M. Tiel Groenestege,* Joost G. Hoenderop,* Lambertus van den Heuvel,†
Nine Knoers,‡ and Rene´ J. Bindels*
Departments of *Physiology, †Pediatrics, and ‡Human Genetics, Nijmegen Centre for Molecular Life Sciences, Radboud
University Nijmegen Medical Centre, Nijmegen, The Netherlands
The kidney is the principal organ responsible for the regulation of the body Mg2 balance. Identification of the gene defect
in hypomagnesemia with secondary hypocalcemia recently elucidated transient receptor potential melastatin 6 (TRPM6) as the
gatekeeper in transepithelial Mg2 transport, whereas its homolog, TRPM7, is implicated in cellular Mg2 homeostasis. The
aim of this study was to determine the tissue distribution in mouse and regulation of TRPM6 and TRPM7 by dietary Mg2
and hormones. This study demonstrates that TRPM6 is expressed predominantly in kidney, lung, cecum, and colon, whereas
TRPM7 is distributed ubiquitously. Dietary Mg2 restriction in mice resulted in hypomagnesemia and renal Mg2 and Ca2
conservation, whereas a Mg2-enriched diet led to increased urinary Mg2 and Ca2 excretion. Conversely, Mg2 restriction
significantly upregulated renal TRPM6 mRNA levels, whereas a Mg2 enriched diet increased TRPM6 mRNA expression in
colon. Dietary Mg2 did not alter TRPM7 mRNA expression in mouse kidney and colon. In addition, it was demonstrated that
17-estradiol but not 1,25-dihydroxyvitamin D3 or parathyroid hormone regulates TRPM6 renal mRNA levels. Renal TRPM7
mRNA abundance remained unaltered under these conditions. The renal TRPM6 mRNA level in ovariectomized rats was
significantly reduced, whereas 17-estradiol treatment normalized TRPM6 mRNA levels. In conclusion, kidney, lung, cecum,
and colon likely constitute the main sites of active Mg2 (re)absorption in the mouse. In addition, Mg2 restriction and
17-estradiol upregulated renal TRPM6 mRNA levels, whereas a Mg2-enriched diet stimulated TRPM6 mRNA expression in
colon, supporting the gatekeeper function of TRPM6 in transepithelial Mg2 transport.
J Am Soc Nephrol 17: 1035–1043, 2006. doi: 10.1681/ASN.2005070700
M g
2 is the second most abundant intracellular cat-
ion and plays an essential role as co-factor in many
enzymatic reactions (1). Mg2 homeostasis depends
on the balance among intestinal absorption, renal excretion,
and exchange with bone (2). Regulation of the total body Mg2
balance principally resides within the kidney that tightly
matches the intestinal absorption of Mg2. Approximately 80%
of the total plasma Mg2 is filtered in the glomeruli (3,4), the
majority of which subsequently is reabsorbed along the
nephron (5). Eighty-five percent of the filtered Mg2 is reab-
sorbed passively in the proximal tubule and the thick ascending
limb of Henle (TAL). The distal convoluted tubule (DCT) reab-
sorbs 5 to 10% of the filtered Mg2, and the reabsorption rate in
this segment defines the final urinary Mg2 concentration.
Mg2 transport in DCT is transcellular in nature and influenced
by dietary Mg2 restriction and a number of hormones (6,7).
However, the molecular details and regulation of this pathway
remain largely unknown (5,6,8,9).
Hereditary disorders with primary hypomagnesemia have
greatly facilitated the identification of epithelial ion transport-
ers in the kidney. For instance, the elucidation of the genetic
basis of isolated dominant hypomagnesemia and hypomag-
nesemia with secondary hypocalcemia resulted in the identifi-
cation of the -subunit of the Na,K-ATPase and the epithe-
lial Mg2 transient receptor potential melastatin 6 (TRPM6),
respectively (10–12). TRPM6, which is a member of the TRP
superfamily, is localized along the apical membrane of the
DCT. Heterologous expression in human embryonic kidney 293
cells of TRPM6 but not TRPM6 mutants identified in patients
with hypomagnesemia with secondary hypocalcemia induces a
Mg2-permeable cation channel that is tightly regulated by the
intracellular Mg2 concentration (13). TRPM6 shows the high-
est homology with TRPM7, which has been identified as a
Mg2-permeable ion channel that primarily is required for
cellular Mg2 homeostasis (13–15).
In analogy with active Ca2 (re)absorption in the distal part
of the nephron and the small intestine through the epithelial
Ca2 channels (transient receptor potential vanilloid 5 [TRPV5]
and TRPV6) (16), the process of transcellular Mg2 transport is
envisaged by the following sequential steps. Driven by a favor-
able transmembrane potential, Mg2 enters the epithelial cell
through the apical epithelial Mg2 channel TRPM6. Next,
Mg2 will diffuse through the cytosol to be extruded actively
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across the basolateral membrane (13). The molecular identity of
these latter Mg2 transporters is not known. Most physiologic
studies favor a Na-dependent exchange mechanism (17). The
Mg2 entry seems to be the rate-limiting step and the site of
regulation.
The aim of our study was to determine the sites of active
Mg2 absorption in mice by investigating the expression profile
of TRPM6. In addition, we established whether TRPM6 is reg-
ulated by dietary Mg2 content and the calciotropic hormones
17-estradiol (17-E2), 1,25-dihydroxyvitamin D3 (1,25(OH)2D3),
and parathyroid hormone (PTH). The effect of dietary Mg2 con-
tent was studied by analyzing TRPM6 regulation at the mRNA
and protein levels and Mg2 excretion and serum levels in
C57BL6 mice fed Mg2-deficient, -normal, and -enriched diets.
Materials and Methods
Animal Studies
To evaluate TRPM6, TRPM7, and TRPV6 mRNA expression in var-
ious tissues, we constructed a cDNA panel. To this end, four C57BL6
mice fed a complete diet that contained 0.2% Mg2 (wt/wt; SSNIFF
spezialdia¨ten GmbH, Soest, Germany) were killed; kidney, spleen,
brain, heart, skeletal muscle, liver, lung, stomach, bone, duodenum,
jejunum, ileum, cecum, and colon were collected; and total RNA was
isolated. To study the effect of dietary Mg2 content on TRPM6 and
TRPM7 expression in kidney and colon, we fed C57BL6 mice (12 wk of
age) for 10 d a Mg2-deficient diet (0.005% wt/wt Mg), a Mg2-normal
diet (0.19% wt/wt Mg), or a Mg2-enriched diet (0.48% wt/wt Mg;
SSNIFF spezialdia¨ten GmbH). During the last 24 h of the dietary
treatment, animals were housed in metabolic cages and 24-h urine was
collected. At the end of the dietary treatment, blood samples were taken
and the animals were killed. Kidney and colon tissues were sampled
and frozen immediately in liquid nitrogen.
The effect of 17-E2 on the renal TRPM6 mRNA expression level was
evaluated by sham-operated, bilateral ovariectomized (OVX), and OVX
rats that received 2  500 g 17-E2/d as described previously (18).
The effect of PTH was studied by sham-operated, parathyroidecto-
mized (PTX), and PTX rats that received 6 units/d bovine PTH as
described previously (19). In addition, the effect of 1,25(OH)2D3 was
studied by 1-hydroxylase knockout (1-OHase/) mice, heterozy-
gous (1-OHase/) mice that are phenotypically identical to wild-
type mice, and 1-OHase/ mice supplemented intraperitoneally
with 1,25(OH)2D3 as described previously (20). The animal ethics board
of the Radboud University Nijmegen approved all experimental pro-
cedures.
Quantitative Real-Time PCR Analysis
Total RNA was extracted from kidney, complete segments of the
intestine, and the other tissues using TriZol Total RNA Isolation Re-
agent (Life Technologies BRL, Breda, The Netherlands) according to the
manufacturer’s protocol. The obtained RNA was subjected to DNase
treatment (Promega, Madison, WI) to prevent genomic DNA contam-
ination. Thereafter, 2 g of RNA was reverse transcribed by Molony-
Murine Leukemia Virus-Reverse Transcriptase (Invitrogen) as de-
scribed previously (21). The cDNA was used to determine TRPM6,
TRPM7, and TRPV6 mRNA expression levels, as well as mRNA levels
of the housekeeping gene hypoxanthine-guanine phosphoribosyl trans-
ferase (HPRT) as an endogenous control. The mRNA expression levels
were quantified by real-time PCR on an ABI Prism 7700 Sequence
Detection System (PE Biosystems, Rotkreuz, Switzerland). Primers and
probes that target the genes of interest were designed using the com- T
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puter program Primer Express (Applied Biosystems, Foster City, CA)
and are listed in Table 1.
In Vivo 45Ca2 Absorption Assay
Intestinal Ca2 absorption was assessed in two groups of C57BL6
mice by measuring the amount of 45Ca2 in serum at early time points
after oral gavage (15 l/g body wt). Mice fasted for 12 h before the test.
Animals were hemodynamically stable under anesthesia during the
experiment. The solution that was used to measure Ca2 absorption
contained 0.1 mM CaCl2, 125 mM NaCl, 17 mM Tris (pH 7.4), and 1.8
g/L fructose and was enriched with 20 Ci 45CaCl2/ml (18 Ci/g; New
England Nuclear, Newton, MA). One group received the 45Ca2 solu-
tion supplemented with MgCl2 to a final concentration of 10 mM,
whereas the 45Ca2 solution of group 2 was not supplemented with
MgCl2. Blood samples were obtained at different time intervals (2, 4, 8,
and 12 min). Radioactive 45Ca2 was analyzed in serum (10 l) by
liquid scintillation counting. The change in the serum Ca2 concentra-
tion was calculated from the 45Ca2 content of the serum samples and
the specific activity of the administrated Ca2.
Analytical Procedures
Serum Mg2 and Ca2 were measured using a colorimetric assay kit
according the manufacturer’s protocol (Roche Diagnostics, Woerden,
The Netherlands). Urinary Mg2 and Ca2 excretion was determined
by atomic absorption spectrophotometry on a Perkin Elmer AAnalyst
300 (Perkin Elmer, Milano, Italy).
Immunohistochemistry
Immunohistochemical staining was performed on 7-m cryosections
of periodate-lysine-paraformaldehyde–fixed kidney samples. Sections
were stained with affinity-purified guinea pig anti-TRPM6, as de-
scribed previously (13). Photographs of the entire cortex were taken
with a Zeiss fluorescence microscope (Sliedrecht, The Netherlands)
equipped with a digital photo camera (Nikon DMX1200). For semi-
quantitative determination of protein levels, images were analyzed
with the Image Pro Plus 4.1 image analysis software (Media Cybernet-
ics, Silver Spring, MD), resulting in quantification of the protein levels
as the mean of integrated optical density (22).
Statistical Analyses
Values are expressed as mean  SEM. Differences between groups
were tested by one-way ANOVA and further evaluated using Fisher
multiple comparison procedure. Differences in means with P  0.05
were considered statistically significant. All analyses were performed
using the Statview Statistical Package (Power PC version 4.51; Berkeley,
CA) on a Macintosh computer.
Results
Tissue Distribution of TRPM6 and TRPM7 in Mouse
To study the quantitative expression levels of TRPM6 and
TRPM7 in various tissues, we constructed a mouse cDNA
panel. Subsequently, we quantified TRPM6 and TRPM7 mRNA
levels by real-time PCR analysis and normalized for HPRT
expression. The highest level of TRPM6 expression was mea-
sured in kidney, intestine, and lung (Figure 1A), whereas
TRPM7 showed a ubiquitous expression pattern (Figure 1B). To
determine in more detail the intestinal site of active Mg2
absorption in relation to transcellular Ca2 absorption, we
quantified mRNA expression levels of TRPM6, TRPM7, and
TRPV6 in different segments of the mouse intestinal tract by
real-time PCR analysis and presented them relative to their
total intestinal expression. The highly Ca2 selective channel
TRPV6 forms the apical entry mechanism in active Ca2 ab-
sorption in the small intestine. TRPM6 was expressed predom-
inantly in cecum and colon, whereas no expression was detect-
Figure 1. Expression profile of transient receptor potential
melastatin 6 (TRPM6) and TRPM7 channels in various mouse
tissues. (A and B) The mRNA expression levels of TRPM6 and
TRPM7 in a panel of mouse tissues were measured by using
quantitative real-time PCR. (C) Quantification of mRNA ex-
pression levels of TRPM6 (f), TRPM7 (), and transient recep-
tor potential vanilloid 6 (TRPV6) (o) along the intestinal tract
are presented as percentage of total intestinal mRNA expres-
sion. mRNA quantified by real-time PCR analysis is calculated
as ratio to the hypoxanthine-guanine phosphoribosyl trans-
ferase (HPRT) RNA level. Data are presented as means  SEM
(n  4).
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able in duodenum and jejunum (Figure 1C). TRPM7 was
equally expressed in the different segments of the intestinal
tract. The epithelial Ca2 channel TRPV6 was expressed pri-
marily in duodenum, cecum, and colon but was not detectable
in jejunum and ileum (Figure 1C).
Urine and Serum Analysis of Mice Fed Various Mg2 Diets
Mice were fed a Mg2-deficient (0.005% wt/wt), -normal
(0.19% wt/wt), or -enriched (0.48% wt/wt) diet for 10 d. At the
end of this period, mice were housed for 24 h in metabolic
cages, and urine samples were collected for investigation of the
electrolyte metabolism of Mg2 and Ca2. The serum Mg2
and Ca2 concentrations and total urinary Mg2 and Ca2
excretion are shown in Figures 2 and 3, respectively. The Mg2-
deficient diet resulted in significant hypomagnesemia (Figure
2B), whereas serum Ca2 values were not significantly altered
in mice fed the various Mg2 diets (Figure 2A). Dietary Mg2
restriction significantly reduced the urinary Mg2 and Ca2
excretion compared with mice fed a Mg2-normal diet (Figure
3). The Mg2-enriched diet significantly increased the urinary
Mg2 and Ca2 excretion, compared with mice fed the normal
diet.
Effect of Dietary Mg2 on 45Ca2 Absorption
To investigate whether dietary Mg2 competes with the rate
of Ca2 absorption, two groups of C57BL6 mice were orally
administered a 45Ca2 solution that contained 0.1 mM Ca2
with or without 10 mM MgCl2. Changes in the serum
45Ca2
concentration (M) were measured within 10 min after ad-
ministration of the 45Ca2 solutions. No significant differences
in the rate of 45Ca2 absorption were observed between the
group that was administered the 45Ca2 solution that contained
an excess of Mg2 and the group that received the 45Ca2
solution only (Figure 4).
Effect of Dietary Mg2 Content on TRPM6 and TRPM7
Expression
The effect of dietary Mg2 content on renal and intestinal
expression of TRPM6 and TRPM7 mRNA was studied. The
Mg2-deficient diet resulted in a significant upregulation of the
renal TRPM6 mRNA level (Figure 5A). In addition, differences
in dietary Mg2 content did not influence renal TRPM7 mRNA
expression (Figure 5B). Next, the abundance of TRPM6 protein
in kidneys was examined. Figure 5C presents representative
immunofluorescence labeling of distal tubules in sections of
kidney from mice fed the Mg2-deficient (0.005% wt/wt), -nor-
mal (0.19% wt/wt), and -enriched (0.48% wt/wt) diets. More
TRPM6 protein was detected in tissue from mice fed the Mg2-
deficient (0.005% wt/wt) diet, as indicated by the increased
staining in the kidney cortex. In these immunopositive tubules,
TRPM6 was localized to the apical membrane of DCT. For
semiquantitative assessment of TRPM6 protein expression, the
relative amounts of immunopositive tubules in the complete
kidney cortex were counted for each kidney section. Figure 5D
presents the average values for each experimental group. The
levels of TRPM6 protein expression in mice fed the Mg2-
deficient (0.005% wt/wt) diet were significantly higher than
those in the other groups. The regulation of TRPM6 and TRPM7
mRNA levels in colon was studied. The Mg2-enriched diet
resulted in an upregulation of TRPM6 mRNA expression level
in colon compared with mice fed the Mg2-deficient diet (Fig-
ure 6A). Like in kidney, variation in dietary Mg2 content did
not alter TRPM7 mRNA expression levels in complete colon
Figure 2. Effect of dietary Mg2 content on serum Mg2 and
Ca2 concentrations. The effect of a Mg2-deficient diet (0.005%
wt/wt), Mg2-normal diet (0.19% wt/wt), and Mg2-enriched
diet (0.48% wt/wt) on serum Mg2 and Ca2 concentration in
mouse. Values are presented as means SEM (n 6). *P 0.05
versus all groups.
Figure 3. Effect of dietary Mg2 content on the total urinary
excretion of Mg2 and Ca2. Net urinary excretion of Mg2 (A)
and Ca2 (B) of mice on a Mg2-deficient diet (0.005% wt/wt),
Mg2-normal diet (0.19% wt/wt), and Mg2-enriched diet
(0.48% wt/wt). Values are presented as means  SEM (n  6).
*P  0.05 versus all groups; #P  0.05 versus all groups.
Figure 4. Effect of dietary Mg2 content on Ca2 absorption.
Changes in the serum 45Ca2 concentration (M) within 10
min after administration of 45Ca2 by oral gavage to C57BL6
mice. Data are averaged values  SEM (n  5) from 12-wk-old
mice. , 0.1 mM Ca2; f, 0.1 mM Ca2  10 mM Mg2.
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sections (Figure 6B) and in the mucosa of the colon (data not
shown).
Hormonal Regulation of Renal TRPM6 and TRPM7
Expression
To determine the effect of the calciotropic hormones, includ-
ing 1,25(OH)2D3, PTH, and 17-E2, on renal mRNA expression
levels of TRPM6 and TRPM7, different animal models were
used. 1-OHase/ mice represent a unique animal model to
study the effect of the hormone 1,25(OH)2D3 (23). To investi-
gate the effect of PTH and 17-E2, we used PTX and OVX rats,
respectively (18,19). Quantitative real-time PCR demonstrated
that renal TRPM6 mRNA expression levels remained unaf-
fected in 1-OHase/ compared with 1-OHase/mice and
1-OHase/ mice supplemented with 1,25(OH)2D3 (Figure
7A). Similarly, no effect of PTH was observed (Figure 7C).
However, a two-fold decrease in TRPM6 mRNA expression
levels was measured in kidneys of ovariectomized (OVX) rats
(Figure 7E). Importantly, administration of 17-E2 normalized
the TRPM6 expression levels in kidney of OVX rats. No differ-
ences in renal expression level of TRPM7mRNAwere observed
in 1-OHase/, PTX, and OVX animals (Figure 7, B, D, and F).
Discussion
Our study shows novel regulatory hallmarks of TRPM6,
further supporting a gatekeeper function in the process of
transepithelial Mg2 transport. First, this epithelial Mg2 chan-
nel was expressed predominantly in mouse epithelia, including
kidney, cecum, colon, and lung. Second, 17-E2 specifically
upregulated TRPM6 mRNA expression in kidney, pointing to
the first magnesiotropic hormone in the maintenance of the
Mg2 balance. Third, Mg2 depletion increased TRPM6 mRNA
expression in kidney, whereas a Mg2-enriched diet increased
TRPM6 mRNA levels in colon. Fourth, the high abundant ex-
pression of TRPM6 in cecum and colon, together with the low
expression level in duodenum and jejunum, suggests that ac-
tive Mg2 absorption takes place primarily in the distal part of
the intestine.
Our study showed that the expression of TRPM6 is restricted
to epithelial tissues, including kidney, whereas TRPM7 can be
found in all tested tissues. Previous immunohistochemical
studies in mouse kidney indeed indicated that TRPM6 is local-
ized exclusively along the apical domain in DCT, which is in
line with the postulated gatekeeper function in the process of
active Mg2 reabsorption (13). Here, we show that Mg2 ex-
cretion and TRPM6 expression in kidney is strongly regulated
by the dietary Mg2 content. Dietary Mg2 restriction resulted
in Mg2 conservation, whereas a Mg2-enriched diet increased
urinary Mg2 excretion. The Mg2-deficient diet resulted in a
significant upregulation of renal TRPM6 mRNA and protein
levels, whereas the enriched diet tended to reduce TRPM6
abundance. TRPM7 expression was not influenced by the di-
etary Mg2 content, supporting a general role in cellular Mg2
homeostasis (14,15). It is interesting that dietary Mg2 restric-
tion in humans also leads to renal Mg2 conservation (24–26),
whereas high dietary Mg2 intake markedly stimulates Mg2
excretion without significant increases in plasma Mg2, which
is in accordance with the results of our study in mouse (27).
Therefore, upregulation of TRPM6 in kidney supports a critical
role of this channel in facilitating maximal Mg2 reabsorption
during Mg2 deficiency.
It is interesting that dietary Mg2 content also influenced the
Ca2 excretion in our study, because Mg2 restriction resulted
in Ca2 conservation, whereas Mg2 supplementation led to an
Figure 5. Effect of dietary Mg2 content on renal expression
levels of TRPM6 and TRPM7. (A and B) Real-time quantitative
PCR was used to determine TRPM6 and TRPM7 mRNA ex-
pression levels in kidney of mice fed the Mg2-deficient diet
(0.005% wt/wt), Mg2-normal diet (0.19% wt/wt), and Mg2-
enriched diet (0.48% wt/wt). (C and D) TRPM6 protein abun-
dance was determined by computerized analysis of immuno-
histochemical images and is presented as integrated optical
density (IOD). Data are presented as means  SEM (n  6).
*P  0.05 versus all groups.
Figure 6. The effect of dietary Mg content on TRPM6 and
TRPM7 mRNA expression in mouse colon. mRNA expression
levels of TRPM6 (A) and TRPM7 (B) mRNA in colon of mice fed
the Mg2-deficient diet (0.005% wt/wt), Mg2-normal diet
(0.19% wt/wt), and Mg2-enriched diet (0.48% wt/wt) were
assessed by quantitative real-time PCR analysis and calculated
as ratio to HPRT RNA. Data are presented as means  SEM
(n  6). *P  0.05 versus 0.005% (wt/wt) Mg2 diet.
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increased urinary Ca2 excretion. In accordance with this find-
ing, Shafik and Quamme (7) showed that urinary Ca2 excre-
tion decreases in rats that are maintained on a low-Mg2 diet.
This coupling between the Mg2 and Ca2 excretion observed
under various dietary Mg2 regimens could occur at the level
of intestinal absorption and/or renal excretion. Because dietary
Mg2 contents did not affect the intestinal Ca2 absorption
rate, the coupling mechanism presumably resides within the
kidney. This suggests the existence of a common pathway or
regulatory mechanism in facilitating urinary Mg2 and Ca2
excretion. In this respect, it is interesting to notice that paracel-
lin-1 has been shown to be instrumental for the paracellular
reabsorption of both divalent cations in TAL (28,29). Impor-
tantly, the majority of the renal Mg2 reabsorption takes place
in this particular segment, where the lumen positive transepi-
thelial potential difference drives paracellular transport of cat-
ions (30). It therefore can be envisaged that Mg2 and Ca2 are
competitively transported by paracellin-1. This competition
suggests that paracellular Ca2 reabsorption in TAL is favored
in the presence of a low luminal Mg2 concentration resulting
from Mg2 deficiency. Conversely, renal Ca2 excretion will be
increased by a high Mg2 load as a result of a Mg2-enriched
diet. Indeed, Ikari et al. (31) demonstrated that 45Ca2 transport
across monolayers of cells that express paracellin-1 is inhibited
by increased Mg2 concentration. In addition, in patients with
Gitelman syndrome or isolated dominant hypomagnesemia,
the observed hypomagnesemia is accompanied by a seriously
diminished urinary Ca2 excretion (32). Therefore, competition
betweenMg2 and Ca2 for a common paracellular route could
explain the observed coupling between the urinary Mg2 and
Ca2 excretion in response to different Mg2 diets. In addition,
the extracellular Ca2 sensing receptor could play a role in the
coupling between the Mg2 and Ca2 excretion under various
dietary Mg2 conditions, because the Ca2 sensing receptor is
Figure 7. Effect of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), parathyroid hormone (PTH), and 17-estradiol (17-E2) on expression
of TRPM6 and TRPM7 channels mRNA in kidney. Effect of 1,25(OH)2D3, PTH, and 17-E2 in renal TRPM6 (A, C, and E) and
TRPM7 (B, D, and F) mRNA expression levels was quantified by real-time PCR analysis and normalized for HPRT expression.
Data are presented as means  SEM (n  4 to 5). *P  0.05 versus all groups.
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believed to sense Ca2 and Mg2 levels and to regulate the
reabsorption of these ions (33).
Despite early proposals for the existence of a specific hor-
monal control of the Mg2 balance, our understanding of the
endocrine factors that regulate circulating or urinary Mg2 is
incomplete. Several hormones, including PTH, calcitonin, vita-
min D, insulin, glucagons, antidiuretic hormone, aldosterone,
and sex steroids, have been reported to influence the Mg2
balance (2,34,35). It was suggested that these hormones are only
indirect regulators of Mg2 homeostasis, because Mg2 lacks a
specific endocrine control similar to what exists for Ca2, Na,
and K (34). It is interesting that our study indicates a magne-
siotropic role for estrogens in Mg2 homeostasis via the regu-
lation of the Mg2 channel TRPM6. In OVX rats, the renal
TRPM6 mRNA level was significantly reduced and subse-
quently normalized by 17-E2 supplementation. It has been
demonstrated that postmenopausal hypermagnesuria signifi-
cantly decreased after estrogen substitution therapy (36,37).
This finding is in line with our results and suggests that 17-E2
increases Mg2 reabsorption via an enhanced renal TRPM6
expression. This stimulatory effect of 17-E2 could be attribut-
able to enhanced transcriptional activity or mRNA stabiliza-
tion. Thus far, detailed analysis did not result in 17-E2–respon-
sive elements in the putative promoter sequence of human and
mouse TRPM6. The magnesiotropic action of estrogens in Mg2
homeostasis via regulation of TRPM6 could be of importance
during the menstrual cycle, pregnancy, and preeclampsia.
However, different studies that have measured estrogen levels
in plasma from preeclamptic women have been inconsistent
(38–41). It is interesting that menstrual migraine is preceded by
a decline in the plasma estrogen level and shows a high inci-
dence of free ionized Mg2 deficiency (42). Further studies
should elucidate the possible interrelationship of estrogens and
TRPM6 in Mg2 homeostasis during the menstrual cycle, preg-
nancy, and preeclampsia.
Previous reports demonstrated that PTH stimulates Mg2
reabsorption in TAL and DCT (43,44). In addition, 1,25(OH)2D3
has been shown to enhance the influx of Mg2 in a mouse DCT
cell line (5). Our study suggests that PTH and 1,25(OH)2D3 are
not involved in the stimulation of Mg2 reabsorption via up-
regulation of renal TRPM6 expression levels because
1,25(OH)2D3 and PTH did not change the TRPM6 expression in
kidney. In addition, Karbach (45,46) demonstrated that cellular
Mg2 transport in rat colon is not responsive to 1,25-dihy-
droxyvitamin D3.
The predominant expression of TRPM6 in cecum and colon
together with the low expression level in duodenum and
jejunum suggests that active Mg2 absorption takes place
exclusively in the distal part of the intestine. Although initial
studies already detected TRPM6 in small intestine, a quan-
titative comparison in the expression along the gastrointes-
tinal tract was not established (11,13). The highly abundant
expression of TRPM6 in colon is further supported by the
fact that colectomy in rat results in a syndrome of Mg2
deficiency with decreased urinary Mg2 excretion, normal
serum Mg2 levels, and, interestingly, decreased bone Mg2
content (47). Remarkably, our data further suggest that ac-
tive intestinal Mg2 absorption only partly overlaps with the
process of active Ca2 absorption. The transepithelial ab-
sorption of Ca2 takes place predominantly in duodenum
and possibly colon as illustrated by the robust expression of
the epithelial Ca2 channel TRPV6 in these particular intes-
tinal segments. TRPV6 constitutes the luminal Ca2 entry
mechanism in active Ca2 absorption (48,49). Therefore, ac-
tive Mg2 and Ca2 absorptions simultaneously take place
in the distal part of the intestine, whereas in duodenum, only
active Ca2 absorption occurs. Expression levels of TRPM6
mRNA in colon were upregulated by the Mg2-enriched
diet, whereas Mg2 restriction did not significantly affect
TRPM6 mRNA expression levels. This suggests that mice can
increase their transcellular Mg2 absorption capacity when
fed a Mg2-enriched diet. In comparison with Ca2 absorp-
tion and TRPV6 expression, Brown et al. (50) demonstrated
that in rats fed a low-Ca2 diet, TRPV6 mRNA levels in
duodenum were significantly increased. In contrast, van
Abel et al. (51) showed that supplementation of 1-
OHase/ mice with a high dietary Ca2 intake resulted in
an increase of duodenal TRPV6 mRNA levels. Therefore, if
the calciotropic hormone 1,25-dihydroxyvitamin D3 is not
present, then duodenal TRPV6 mRNA expression is upregu-
lated in response to high dietary Ca2 intake. The important
difference between intestinal regulation of TRPM6 and
TRPV6 is that no magnesiotropic hormone has been identi-
fied to regulate intestinal TRPM6 expression and thereby
Mg2 absorption. We suggest that, physiologically, an excess
of Mg2 absorption as a result of high dietary Mg2 intake
together with TRPM6 upregulation in colon can be totally
corrected by the kidney. Normally, the kidney excretes only
2 to 4% of the filtered Mg2 but is capable of increasing
fractional excretion to nearly 100% in the face of increased
serum Mg2 levels (52). Therefore, the absence of a magne-
siotropic hormone that regulates intestinal TRPM6 expres-
sion and Mg2 absorption could explain why TRPM6 mRNA
levels in colon are upregulated in response to high dietary
Mg2 content.
The unaltered expression levels of TRPM6 mRNA in colon
during Mg2 restriction suggests that the Mg2 absorptive
capacity is sufficient to obtain maximal transcellular Mg2
transport. The ubiquitous and diet-unresponsive expression of
TRPM7 suggests that this particular Mg2 channel does not
participate in the extracellular Mg2 homeostasis. In line with
previous studies, this indicates that TRPM7 is involved primar-
ily in cellular Mg2 homeostasis (14,15).
It is interesting that besides kidney and the intestine, TRPM6
is highly abundant in lung tissue. The exact function of TRPM6
in this organ, however, remains to be elucidated. The impor-
tance of Mg2 in lung is supported by the fact that dietary
Mg2 intake is related directly to lung function, airway reac-
tivity, and respiratory symptoms in the general population (53).
Moreover, treatment of patients who have chronic asthma is
currently receiving attention because of a role for Mg2 in
relaxation of arterial and bronchial smooth muscle cells (54–
56). Further research certainly is needed to determine the pre-
cise function of TRPM6 in lung (patho)physiology.
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Conclusion
TRPM6 is expressed predominantly in kidney, cecum, colon,
and lung, suggesting that these organs are involved primarily
in Mg2 (re)absorption. Furthermore, we provide evidence that
the intestinal site of active Mg2 absorption is located primarily
in the distal part of the intestine. In addition, 17-E2 and dietary
Mg2 are positively involved in the regulation of TRPM6,
underlining the gatekeeper function of this epithelial Mg2
channel.
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